journal article·2019-12-04Open access

Co-encapsulation of magnetic Fe 3 O 4 nanoparticles and doxorubicin into biocompatible PLGA-PEG nanocarriers for early detection and treatment of tumours

Chenghua Liang, Nan Li, Zikai Cai, Rongpu Liang, Xiaoming Zheng, Li Deng, Longbao Feng, Rui Guo, Bo Wei

Abstract

At present, cancer is the first cause of death for humans, but early detection and treatment can help improve prognoses and reduce mortality. However, further development of carrier-assistant drug delivery systems (DDSs) is retarded by the aspects such as the low drug-carrying capacity, carrier-induced toxicity and immunogenicity, complex synthesis manipulation. The development of nanoscale drug delivery systems (NDDS) have been rapidly developed to address these issues. In this article, we used PLGA-PEG with good biocompatibility to encapsulate Fe3O4 nanoparticles (a magnetic resonance imaging contrast agent) and DOX (an antitumour drug) via the emulsion-solvent evaporation method, aimed at achieving a dual function of the early detection and the treatment of mammary cancer. The results showed that the Fe3O4/DOX/PLGA-PEG nanoparticles had a relatively uniform size, a high carrier rate of Fe3O4 and high encapsulation efficiency of DOX, and a relatively high activity of released DOX within 120 h. In addition, in vitro studies showed that the Fe3O4/DOX/PLGA-PEG nanoparticles were cytocompatibility in NIH 3T3 fibroblast cells culture study while had a special effect on destroying human breast cancer MCF-7 cells compared with pure DOX solution. In vitro studies revealed that the Fe3O4/DOX/PLGA-PEG enabled enhanced T2 contrast magnetic resonance. Overall, our multifunctional Fe3O4/DOX/PLGA-PEG nanoparticles, composed of biocompatible substances and therapeutic/imaging materials, have great potential for the early detection of cancer and accurate drug delivery via the dynamic monitoring using MRI.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-Sen University

Department of Stomatology Center, Shenzhen People's Hospital, Second Clinical Medical School of Jinan University, 1st Affiliated Hospital of Southern University of Science and Technology

Beogene Biotech (Guangzhou) CO., LTD

Key Laboratory of Biomaterials of Guangdong Higher Education Institutes, Guangdong Provincial Engineering and Technological Research Center for Drug Carrier Development, Department of Biomedical Engineering, Jinan University

Funding

Fundamental Research Funds for the Central Universities · Natural Science Foundation of China · Science and Technology Programme of Guangzhou · Pearl River S&T Nova Programme of Guangzhou · Science and Technology Project of Guangdong Province

References (39)

Show source-provided references
1. Discov EDJM, Rana S, Dixit S, et al. Anticancer effects of chemotherapy and nature products. J Med Discov. 2017;2:jmd17008.
2. 10.1182/blood.V97.1.26410.1182/blood.V97.1.264 ↗
3. 10.1002/adhm.20160028710.1002/adhm.201600287 ↗
4. 10.1016/j.canlet.2011.08.02410.1016/j.canlet.2011.08.024 ↗
5. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
6. 10.1007/s11523-015-0379-410.1007/s11523-015-0379-4 ↗
7. 10.1016/j.jconrel.2018.08.00810.1016/j.jconrel.2018.08.008 ↗
8. 10.1016/j.addr.2015.01.00210.1016/j.addr.2015.01.002 ↗
9. 10.1016/j.addr.2012.10.00210.1016/j.addr.2012.10.002 ↗
10. 10.1016/j.addr.2010.04.00910.1016/j.addr.2010.04.009 ↗
11. 10.1371/journal.pone.006452610.1371/journal.pone.0064526 ↗
12. 10.1016/j.tox.2007.09.02610.1016/j.tox.2007.09.026 ↗
13. 10.1016/j.biomaterials.2013.08.03010.1016/j.biomaterials.2013.08.030 ↗
14. 10.4155/tde.13.3810.4155/tde.13.38 ↗
15. 10.3390/nano602002610.3390/nano6020026 ↗
16. 10.1021/acs.biomac.8b0013010.1021/acs.biomac.8b00130 ↗
17. Bi Y, Liu L, Lu Y, et al. T7 peptide-functionalized PEG-PLGA micelles loading with carmustine for targeting therapy of glioma. ACS Appl Mater Interfaces. 2016;8(41):27465–27473.
18. 10.1039/C8TB00748A10.1039/C8TB00748A ↗
19. 10.1016/j.msec.2016.11.05310.1016/j.msec.2016.11.053 ↗
20. 10.1016/j.msec.2015.10.08310.1016/j.msec.2015.10.083 ↗
21. 10.4028/www.scientific.net/AMR.393-395.93910.4028/www.scientific.net/AMR.393-395.939 ↗
22. 10.1002/jbm.b.3161410.1002/jbm.b.31614 ↗
23. 10.1021/am406008k10.1021/am406008k ↗
24. 10.1016/j.carbpol.2016.02.03210.1016/j.carbpol.2016.02.032 ↗
25. 10.1039/C6BM00444J10.1039/C6BM00444J ↗
26. Jun-Qing S, Wang XJ, Zhu XL, et al. Multifunctional SPIO/DOX-loaded A54 homing peptide functionalized dextran-g-PLGA micelles for tumor therapy and MR imaging. Sci Rep. 2016;6.
27. 10.1038/srep2314010.1038/srep23140 ↗
28. 10.1016/j.biomaterials.2006.09.04710.1016/j.biomaterials.2006.09.047 ↗
29. 10.1021/acsami.5b0102710.1021/acsami.5b01027 ↗
30. 10.1002/adhm.20140073610.1002/adhm.201400736 ↗
31. 10.1016/j.apradiso.2011.05.01110.1016/j.apradiso.2011.05.011 ↗
32. 10.1021/acsami.7b1016310.1021/acsami.7b10163 ↗
33. 10.1021/nn103362n10.1021/nn103362n ↗
34. Standard practice for assessment of hemolytic properties of materials ASTM 2008 F756-08.
35. Kim YA, Sun YK. Measurement of PT, aPTT, and fibrinogen by automatic coagulation analyzer, ACL9000. J Clin Pathol Qual Control. 2002;23:247–252.
36. Yao Y, Zhao D, Li N, et al. Multifunctional Fe3O4@polydopamine@DNA-fueled molecular machine for magnetically targeted Intracellular Zn2+ imaging and fluorescence/MRI guided photodynamic-photothermal therapy. Anal Chem. 2019;91:7850-7857.
37. 10.3390/pharmaceutics1003014410.3390/pharmaceutics10030144 ↗
38. Tang H, Yuan G, Li P, et al. In vivo targeted, responsive and synergistic cancer nanotheranostics by MRI-guided synergistic HIFU ablation and chemotherapy. ACS Appl Mater Interfaces. 2018;10, acsami.8b01967.
39. 10.1016/j.actbio.2013.09.00710.1016/j.actbio.2013.09.007 ↗